{"title":"药品成本会压倒医疗网络吗?","authors":"","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>A crisis looms as medical networks, already reeling from ongoing drug cost increases, face the Viagra crisis and anticipate the release of whole groups of expensive new therapeutics on the market.</p>","PeriodicalId":80073,"journal":{"name":"Medical network strategy report","volume":"7 8","pages":"1, 6-9"},"PeriodicalIF":0.0000,"publicationDate":"1998-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Will pharmacy costs overwhelm medical networks?\",\"authors\":\"\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>A crisis looms as medical networks, already reeling from ongoing drug cost increases, face the Viagra crisis and anticipate the release of whole groups of expensive new therapeutics on the market.</p>\",\"PeriodicalId\":80073,\"journal\":{\"name\":\"Medical network strategy report\",\"volume\":\"7 8\",\"pages\":\"1, 6-9\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1998-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical network strategy report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical network strategy report","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
A crisis looms as medical networks, already reeling from ongoing drug cost increases, face the Viagra crisis and anticipate the release of whole groups of expensive new therapeutics on the market.